Gynecological
Why are obstetricians among the top billers for group psychotherapy in Illinois?
by Charles Ornstein, ProPublica. This story was co-published with The Chicago Tribune.
UPDATE: FDA panel inconclusive on power morcellators
Debate heats up during FDA meeting over uterine surgical device and cancer risk
Scores of speakers expressed outrage before a panel of FDA experts gathered at a public meeting yesterday and today to discuss the future of laparoscopic power morcellators (LPMs), devices used to break up and extract tissue during minimally invasive gynecologic surgeries.
Covidien logs $180M charge over pelvic mesh lawsuits
Gynesonics adds $6M for fibroid device
Gynesonics added another $6.3 million to its coffers as it looks to bring the latest iteration of its VizAblate fibroid device to the U.S. market.
Patient group wants J&J probe over pelvic mesh | MassDevice.com On Call
MASSDEVICE ON CALL — The controversy over transvaginal mesh implants is heating up in Florida, with patient advocates calling on authorities to investigate Johnson & Johnson (NYSE:JNJ) and its leadership.
Scotland curbs use of transvaginal mesh amid global outcry
Scottish health regulators are looking to curb use of transvaginal mesh products while independent investigators look into claims that the medical implants hurt women.
Intuitive Surgical sponsors women’s cancer registry
FDA panel to evaluate power morcellators
The FDA said today that it plans to convene an advisory panel to evaluate the use power morcellators in gynecological procedures after the devices, used to remove uterine tissue, were linked with the spread of cancer.